Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
about
Risk impact of edoxaban in the management of stroke and venous thromboembolismAsian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral AnticoagulantsNon-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesChallenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A ReviewHow to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillationRisk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-AnalysisPractical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary careSpotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatranAnticoagulation in atrial fibrillationCerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage riskTraumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literatureAntithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.Outcome of intracerebral hemorrhage associated with different oral anticoagulants.Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.Trials of novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarinDabigatran in secondary stroke prevention: clinical experience with 106 patients.Evolving use of new oral anticoagulants for treatment of venous thromboembolismDabigatran: patient management in specific clinical settings.Expanding use of new oral anticoagulantsAnticoagulation reversal in the era of the non-vitamin K oral anticoagulants.Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation.Target-specific oral anticoagulants in atrial fibrillation: results of phase III trials and comments on sub-analyses.European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.Interrupting anticoagulation in patients with nonvalvular atrial fibrillation.Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis.Dabigatran etixilate and traumatic brain injury: Evolving anticoagulants require evolving care plansEmergency reversal of dabigatran for emergency surgery.Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-AnalysisNon-vitamin K antagonist oral anticoagulants: new choices for patient management in atrial fibrillation.Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies.Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant typeLong-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studiesThe clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patientsAnticoagulation in atrial fibrillation: the present and the future.Perioperative management of coagulation in nontraumatic intracerebral hemorrhageA new era of stroke prevention in atrial fibrillation: comparing a new generation of oral anticoagulants with warfarin
P2860
Q26738846-40B4DDB1-07B6-4B6E-9722-7AB58EFF8950Q26750467-27E2DD5A-BDE5-49E0-A493-C583A3810389Q26750767-4E033298-6BDB-4C82-B855-6EA87A15F785Q26765949-7E251413-CE61-4427-AA2F-CE7487B94ACDQ26776413-BC2A89A9-6A27-46ED-B9BC-63579CF24F5AQ26783473-E62CF8F3-6570-4A4E-9633-75884159583BQ26785480-38E234C8-D184-4A69-8C21-CB8B879EC388Q28066262-EB72F786-5282-482F-B850-424429CAC297Q28315636-93E3D3C6-83D6-44E4-B225-B19DF34D4A19Q30570918-4A48B348-C602-4374-9092-5F8FFB598983Q33165278-F377C013-3A9C-4393-B896-DC2738C7DF60Q33427274-35CAF53E-11C5-48CE-B0EC-5C3FEECD6028Q33552973-426ED203-0B54-4404-B946-7D873645128EQ33581189-71069655-38FE-4124-AF17-2BB59708928AQ33617298-5229D1A3-0620-49DB-BD5D-A2600453F2DFQ33750215-9C5D7AEF-3C8E-449D-9765-095FFFEE9BFAQ33911981-7DB00BCE-8FF9-4742-93A1-F775AAFC2A31Q33977604-BE5E4EF6-AFA4-473C-A2FC-A1A9C7AF76BBQ34009254-134657BD-DFF3-47F8-8243-008B4CBB0081Q34047821-2E89870E-E858-4EFF-9A4B-331CDEA42854Q34196100-FABE2010-9D0F-4C60-A1D9-D3402D18D107Q34312531-32080306-078D-4EDA-8BFC-7CCB11FC37B1Q34469002-BE50C365-CC27-48F1-B598-128022683839Q34551073-1E17DDB3-D474-42D0-82F5-43001B9DEA08Q34650638-24FBC403-8025-4132-BBFD-E4BB62F1BD48Q34651051-88BFAB73-ED7C-4F37-BB28-42738B0671A9Q34688742-A433F3E9-EF95-4994-A0E9-B6E2F8268D9FQ35224171-A7D439B5-B24A-4D5E-9420-04F9E5F0884EQ35226978-F7C837BE-4A71-43C3-9207-01B48A048871Q35578443-8EA4D307-0E51-4055-928C-AD730E6A1D2AQ35974298-6AA08A5D-8393-424F-8FC0-154D22E3171EQ36100271-49875960-8791-45F8-BADA-FC5D21632D15Q36567348-119C2D0B-C39F-43F5-8D0F-698505922D02Q36645135-1305256F-5E95-4200-887B-BA2EFD830CD1Q36909458-9AD5C0F2-2266-4DA4-ADA8-72638ED9DD20Q36984232-1E988161-8560-456A-904E-0CD8F8873D56Q37014482-F7DDDFBD-A21B-4A53-891D-E35D4DDDF031Q37082589-441B8F80-6480-4E67-A5E2-53D6AAAB8BA8Q37274433-6DDB1F8E-7ACA-4E14-B2D5-3105942B9F66Q37312021-A15AAF27-24F0-4AD2-B36C-2D75A05B0F43
P2860
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@ast
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@en
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@nl
type
label
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@ast
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@en
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@nl
prefLabel
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@ast
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@en
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@nl
P2093
P50
P921
P1433
P1476
Intracranial hemorrhage in atr ...... r dabigatran: the RE-LY trial.
@en
P2093
Michael D Ezekowitz
Paul A Reilly
Robert G Hart
Stuart J Connolly
P304
P356
10.1161/STROKEAHA.112.650614
P407
P577
2012-04-05T00:00:00Z